Northfield Laboratories

Northfield Laboratories

Northfield Laboratories Inc. ( former NASDAQ: NFLD ) was the maker of PolyHeme, a hemoglobin-based oxygen carrier (HBOC). The company was based in Evanston, Illinois, with Dr. Steven A. Gould as its Chief Executive Officer. As of May 31, 2005, the company had 68 employees. It was founded in 1985 and has since been a mainly Research and Development company. Northfield's only product was PolyHeme, an oxygen-carrying blood substitute, which failed to receive FDA regulatory approval. On May 9, 2009, after being informed by the FDA the product's risks outweighed the benefits, the company shut down operations. During their operations, they incurred losses of about 220 million dollars.[1] The corporation was also heaviliy criticised for its unethical human experimentation practices [2]

See also

References

  1. ^ http://www.chicagotribune.com/business/chi-sat-northfield-0509-may09,0,1111961.story, retrieved May 9, 2009
  2. ^ http://blogs.abcnews.com/theblotter/2007/05/test_of_controv.html

External links